Cutler Group LP Allogene Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Apr 14, 2022	SELL	$7.65 - $15.29 $3,060 - $6,116	-400 Reduced 13.33%	2,600 $39,000
Q4 2021 Jan 18, 2022	BUY	$13.13 - $24.52 $31,512 - $58,848	2,400 Added 400.0%	3,000 $26,000
Q2 2021 Jul 19, 2021	BUY	$23.49 - $35.8 $14,093 - $21,480	600 New	600 $0
Q4 2020 Jan 21, 2021	SELL	$25.24 - $43.45 $55,528 - $95,590	-2,200 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$18.39 - $54.04 $5,517 - $16,212	-300 Reduced 12.0%	2,200 $6,000
Q3 2019 Oct 28, 2019	BUY	$26.11 - $32.99 $65,275 - $82,475	2,500 New	2,500 $10,000

165

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $279M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.